2021 EBMT指南建议：COVID-19流行期间造血干细胞移植治疗自身免疫性疾病

2021-05-24 欧洲血液和骨髓移植小组 Bone Marrow Transplant.2021 May 24.

2021年5月，欧洲血液和骨髓移植学会(EBMT)发布了COVID-19流行期间造血干细胞移植治疗自身免疫性疾病的共识建议。COVID-19的流行给全球的公共卫生带来巨大威胁，本文主要针对在COVID

中文标题：

英文标题：

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

发布机构：

欧洲血液和骨髓移植小组

发布日期：

2021-05-24

简要介绍：

2021年5月，欧洲血液和骨髓移植学会(EBMT)发布了COVID-19流行期间造血干细胞移植治疗自身免疫性疾病的共识建议。COVID-19的流行给全球的公共卫生带来巨大威胁，本文主要针对在COVID-19流行期间造血干细胞移植治疗自身免疫性疾病的相关内容提供指南和建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=3a5971c0021135df, title=2021 EBMT指南建议：COVID-19流行期间造血干细胞移植治疗自身免疫性疾病, enTitle=Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations, guiderFrom=Bone Marrow Transplant.2021 May 24., authorId=0, author=, summary=2021年5月，欧洲血液和骨髓移植学会(EBMT)发布了COVID-19流行期间造血干细胞移植治疗自身免疫性疾病的共识建议。COVID-19的流行给全球的公共卫生带来巨大威胁，本文主要针对在COVID, cover=https://img.medsci.cn/2021618/1623993220012_2020535.jpg, journalId=0, articlesId=null, associationId=1049, associationName=欧洲血液和骨髓移植小组, associationIntro=null, copyright=0, guiderPublishedTime=Mon May 24 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年5月，欧洲血液和骨髓移植学会(EBMT)发布了COVID-19流行期间造血干细胞移植治疗自身免疫性疾病的共识建议。COVID-19的流行给全球的公共卫生带来巨大威胁，本文主要针对在COVID-19流行期间造血干细胞移植治疗自身免疫性疾病的相关内容提供指南和建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=8486, tagName=造血干细胞移植)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8486, guiderKeyword=造血干细胞移植, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6985, appHits=37, showAppHits=0, pcHits=449, showPcHits=6948, likes=0, shares=3, comments=6, approvalStatus=1, publishedTime=Fri Jun 18 13:15:45 CST 2021, publishedTimeString=2021-05-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Jun 18 13:13:47 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 07:03:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 EBMT指南建议：COVID-19流行期间造血干细胞移植治疗自身免疫性疾病.pdf)])

2021 EBMT指南建议：COVID-19流行期间造血干细胞移植治疗自身免疫性疾病.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2113507, encodeId=3e87211350e99, content=学习了<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8bc2098575, createdName=1591f6035fm, createdTime=Tue Feb 07 17:12:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=976099, encodeId=80229e609906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:31:34 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975452, encodeId=26b19e5452cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=deed5151667, createdName=Hopper, createdTime=Mon Jun 21 13:46:12 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974646, encodeId=980f9e4646a7, content=造血干细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/66e2f5918ad342cab6c399b3723aacb6/07c2807c713c4a54a8bb5578a764e41b.jpg, createdBy=198a5452452, createdName=Ms20210609, createdTime=Fri Jun 18 13:53:23 CST 2021, time=2021-06-18, status=1, ipAttribution=)]
2023-02-07 1591f6035fm 来自江西省

学习了#Med#

36 0
[GetPortalCommentsPageByObjectIdResponse(id=2113507, encodeId=3e87211350e99, content=学习了<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8bc2098575, createdName=1591f6035fm, createdTime=Tue Feb 07 17:12:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=976099, encodeId=80229e609906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:31:34 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975452, encodeId=26b19e5452cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=deed5151667, createdName=Hopper, createdTime=Mon Jun 21 13:46:12 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974646, encodeId=980f9e4646a7, content=造血干细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/66e2f5918ad342cab6c399b3723aacb6/07c2807c713c4a54a8bb5578a764e41b.jpg, createdBy=198a5452452, createdName=Ms20210609, createdTime=Fri Jun 18 13:53:23 CST 2021, time=2021-06-18, status=1, ipAttribution=)]
2021-06-23 湘雅科教

学习了

91 0
[GetPortalCommentsPageByObjectIdResponse(id=2113507, encodeId=3e87211350e99, content=学习了<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8bc2098575, createdName=1591f6035fm, createdTime=Tue Feb 07 17:12:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=976099, encodeId=80229e609906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:31:34 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975452, encodeId=26b19e5452cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=deed5151667, createdName=Hopper, createdTime=Mon Jun 21 13:46:12 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974646, encodeId=980f9e4646a7, content=造血干细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/66e2f5918ad342cab6c399b3723aacb6/07c2807c713c4a54a8bb5578a764e41b.jpg, createdBy=198a5452452, createdName=Ms20210609, createdTime=Fri Jun 18 13:53:23 CST 2021, time=2021-06-18, status=1, ipAttribution=)]
2021-06-21 Hopper

学习了

69 0
[GetPortalCommentsPageByObjectIdResponse(id=2113507, encodeId=3e87211350e99, content=学习了<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8bc2098575, createdName=1591f6035fm, createdTime=Tue Feb 07 17:12:12 CST 2023, time=2023-02-07, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=976099, encodeId=80229e609906, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Jun 23 10:31:34 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975452, encodeId=26b19e5452cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=deed5151667, createdName=Hopper, createdTime=Mon Jun 21 13:46:12 CST 2021, time=2021-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974646, encodeId=980f9e4646a7, content=造血干细胞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210609/66e2f5918ad342cab6c399b3723aacb6/07c2807c713c4a54a8bb5578a764e41b.jpg, createdBy=198a5452452, createdName=Ms20210609, createdTime=Fri Jun 18 13:53:23 CST 2021, time=2021-06-18, status=1, ipAttribution=)]
2021-06-18 Ms20210609

造血干细胞

83 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2021 EBMT指南建议：COVID-19流行期间造血干细胞移植治疗自身免疫性疾病

相关指南

拓展阅读

科室

工具

服务